VMP 15048111000001106

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Icatibant 30mg/3ml solution for injection pre-filled syringes
BNF code 0304030H0AAAAAA
Virtual Therapeutic Moiety Icatibant
Abbreviated name Icatibant 30mg/3ml inj pre-filled syringes
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 3.000
Unit dose form units ml
Unit dose unit of measure pre-filled disposable injection
Virtual Product Ingredient
Ingredient Icatibant acetate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 703834005
Strength value numerator 10.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.subcutaneous
Dose Form
Formulation Solution for injection
Drug Route
Route Subcutaneous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Firazyr 30mg/3ml solution for injection pre-filled syringes (Takeda UK Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Celix Pharma Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Cipla EU Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Piramal Critical Care Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Sandoz Ltd)
Icatibant 30mg/3ml solution for injection pre-filled syringes (Wockhardt UK Ltd)
Virtual Medicinal Product Packs
Icatibant 30mg/3ml solution for injection pre-filled syringes 1 pre-filled disposable injection
Icatibant 30mg/3ml solution for injection pre-filled syringes 3 pre-filled disposable injection

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.

Feedback